Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de la Victoria (31)

2023

  1. Unusual Surge of Acute Hepatitis A Cases in 2016 and 2017 in Malaga, Southern Spain: Characterization and Relationship with Other Concurrent European Outbreaks

    Journal of Clinical Medicine, Vol. 12, Núm. 20

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  2. Synergic effect of metabolic syndrome and lipodystrophy on oxidative stress and inflammation process in treated HIV-patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 6, pp. 310-316

2021

  1. A pandemic within other pandemics. When a multiple infection of a host occurs: Sars-cov-2, hiv and mycobacterium tuberculosis

    Viruses, Vol. 13, Núm. 5

  2. Cryptococcal infection in HIV-infected patients with CD4+ T-cell counts under 100/μL diagnosed in a high-income country: a multicentre cohort study

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1171.e1-1171.e7

  3. Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

    Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810

  4. Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain

    HIV Medicine, Vol. 22, Núm. 5, pp. 379-386

2020

  1. Factors associated with the number of drugs in darunavir/cobicistat regimens

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 1, pp. 208-214

  2. High Prevalence of Sequences Included in Transmission Clusters within Newly Diagnosed HIV-1 Patients in Southern Spain (2004-2015)

    Microbial Drug Resistance, Vol. 26, Núm. 9, pp. 1090-1097

2019

  1. Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy

    Annals of Hematology, Vol. 98, Núm. 8, pp. 1953-1959

  2. Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort

    PLoS ONE, Vol. 14, Núm. 8

  3. Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice

    The Journal of antimicrobial chemotherapy, Vol. 74, Núm. 6, pp. 1693-1700

2018

  1. Emergence as an outbreak of the HIV-1 CRF19_cpx variant in treatment-naïve patients in southern Spain

    PLoS ONE, Vol. 13, Núm. 1

  2. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

    Medicine (United States), Vol. 97, Núm. 38

  3. Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment

    Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337

  4. Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study

    Journal of the International Association of Providers of AIDS Care, Vol. 17

2017

  1. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

    PLoS ONE, Vol. 12, Núm. 9

  2. Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme

    PLoS ONE, Vol. 12, Núm. 3

  3. Response to bile salts in clinical strains of Acinetobacter baumannii lacking the adeABC efflux pump: Virulence associated with quorum sensing

    Frontiers in Cellular and Infection Microbiology, Vol. 7, Núm. MAY

2016

  1. Aspectos farmacológicos de darunavir/cobicistat

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, pp. 30-33